These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 24991971)
1. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma. Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971 [TBL] [Abstract][Full Text] [Related]
2. The spectrum of histopathological changes encountered in pancreatectomy specimens after neoadjuvant chemoradiation, including subtle and less-well-recognised changes. Kalimuthu SN; Serra S; Dhani N; Chetty R J Clin Pathol; 2016 Jun; 69(6):463-71. PubMed ID: 26915370 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry. Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519 [TBL] [Abstract][Full Text] [Related]
5. Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary mucinous neoplasm undergoing partial pancreatectomy. Mori Y; Ohtsuka T; Tamura K; Ideno N; Aso T; Kono H; Nagayoshi Y; Ueda J; Takahata S; Aishima S; Ookubo F; Oda Y; Tanaka M Surgery; 2014 Jan; 155(1):67-73. PubMed ID: 24183345 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma. Korpela T; Ristimäki A; Udd M; Vuorela T; Mustonen H; Haglund C; Kylänpää L; Seppänen H BMC Cancer; 2022 Jan; 22(1):23. PubMed ID: 34980011 [TBL] [Abstract][Full Text] [Related]
7. Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting. Fujii T; Satoi S; Yamada S; Murotani K; Yanagimoto H; Takami H; Yamamoto T; Kanda M; Yamaki S; Hirooka S; Kon M; Kodera Y J Gastroenterol; 2017 Jan; 52(1):81-93. PubMed ID: 27169844 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma. Chatterjee D; Katz MH; Rashid A; Estrella JS; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Abbruzzese JL; Fleming JB; Wang H Histopathology; 2013 Dec; 63(6):841-51. PubMed ID: 24111684 [TBL] [Abstract][Full Text] [Related]
9. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis. van Erning FN; Mackay TM; van der Geest LGM; Groot Koerkamp B; van Laarhoven HWM; Bonsing BA; Wilmink JW; van Santvoort HC; de Vos-Geelen J; van Eijck CHJ; Busch OR; Lemmens VE; Besselink MG; Acta Oncol; 2018 Dec; 57(12):1655-1662. PubMed ID: 30264642 [TBL] [Abstract][Full Text] [Related]
10. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma. Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666 [TBL] [Abstract][Full Text] [Related]
11. Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients. Hwang IK; Kim H; Lee YS; Kim J; Cho JY; Yoon YS; Han HS; Hwang JH Cancer Sci; 2015 Oct; 106(10):1408-13. PubMed ID: 26183380 [TBL] [Abstract][Full Text] [Related]
12. The role of inflammation in pancreatic cancer. Hausmann S; Kong B; Michalski C; Erkan M; Friess H Adv Exp Med Biol; 2014; 816():129-51. PubMed ID: 24818722 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic characteristics of fibrous mass-forming chronic pancreatitis]. Chang XJ; Chen Y; Zhang J; Shi M; Wang Y; Zhu MH Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):366-71. PubMed ID: 24060068 [TBL] [Abstract][Full Text] [Related]
14. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans. Takahashi M; Hori M; Ishigamori R; Mutoh M; Imai T; Nakagama H Cancer Sci; 2018 Oct; 109(10):3013-3023. PubMed ID: 30099827 [TBL] [Abstract][Full Text] [Related]
15. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN). McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698 [TBL] [Abstract][Full Text] [Related]
16. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer. Saloman JL; Albers KM; Li D; Hartman DJ; Crawford HC; Muha EA; Rhim AD; Davis BM Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3078-83. PubMed ID: 26929329 [TBL] [Abstract][Full Text] [Related]
17. Adipose Triglyceride Lipase (ATGL) Expression Is Associated with Adiposity and Tumor Stromal Proliferation in Patients with Pancreatic Ductal Adenocarcinoma. Grace SA; Meeks MW; Chen Y; Cornwell M; Ding X; Hou P; Rutgers JK; Crawford SE; Lai JP Anticancer Res; 2017 Feb; 37(2):699-703. PubMed ID: 28179319 [TBL] [Abstract][Full Text] [Related]
18. Update on the management of pancreatic cancer: surgery is not enough. Ansari D; Gustafsson A; Andersson R World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920 [TBL] [Abstract][Full Text] [Related]